Bayer to consolidate GMO research in Belgium
Bayer CropScience is to consolidate its European research activities in plant biotechnology at its innovation centre in Ghent, Belgium. It has also decided to discontinue its research into nutrition specialty ingredients at its site in Potsdam, Germany. The proportion of the company’s R&D budget allocated to seeds and traits is to increase from the current 20% to 25% in 2012. It plans to invest some €750 million ($1,020 million at the current rate) to develop new products in its seeds and traits business from 2008 to 2012 ( Agrow No 553, p 3). The company also intends to further extend its R&D capacities in North America.